Publication for Xpo1 and Cse1l

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
mmu	Xpo1	exportin 1	103573			[link]
mmu	Cse1l	chromosome segregation 1-like (S. cerevisiae)	110750

Pubmed ID	Priority	Text
25948791	0.98	XPO2-7), XPO1/CRM1 is the sole nuclear exporter for some of the major tumor suppressors (i.e., p53), cell cycle regulators (i.e., CDKN1a) and growth promoting proteins (i.e., survivin).
24490135	0.97	XPO1, XPO4, and Cse1L were also more highly expressed in mESCs compared to MEFs.
27232334	0.97	Xpo1 and Xpo5 are additional members of the exportin family, have some structural similarities to Xpo2 and mediate the export of proteins with a nuclear export signal and of RNA respectively.
20886002	0.95	Exp1 and Exp2, therefore reflecting the impact of CLA on adipose miRNAs.
	0.94	Exp1 and Exp2).
	0.86	Exp1 and only the highest dose of CLA in Exp2 (CLA4) produced a significant increase of miR-221 with respect to both CLA3 and control groups (P<0.01).
	0.81	Exp1 and, despite moderate hyperglucemia and hyperinsulinemia in Exp2, insulin sensitivity, assayed by the revised quantitative insulin sensitivity check index is preserved in this experimental setting.
28332554	0.95	EXP 1 (i.e., discontinuous oral feeding with fucoidan) exhibited reduced efficacy in inhibiting tumor growth compared with that of the EXP 2 continuous fucoidan treatment.
	0.71	EXP 2 were significantly reduced compared with those of the mice in EXP 1 (Fig. 1B and C).
29379507	0.95	Exp#1, and p = 0.027 in Exp#2; Figure 4D).
24068922	0.93	Exp 1: F2,16 = 6.0, p = 0.011, Exp 2: F2,25 = 21, p<0.001) as well as the density of resistant transmission stages (Fig. 2IJ).
	0.86	Exp 1: F2,16 = 7.3, p = 0.006, Exp 2: F2,25 = 34, p<0.001).
	0.73	Exp 1: F2,16 = 15, p<0.001, Exp 2: F2,25 = 29, p<0.001).
30515275	0.92	Exp-1 and Exp-2 could be explained by the following; (1) timing to start AfGAE administration, (2) tissue-specificity of certain cytokine productions, and (3) different sensitivity of certain cytokine production by local inflammation vs. systemic inflammation due to aging.
	0.85	Exp-1 (P < 0.001), whereas this dose-dependency phenomenon was not observed in a treatment study, Exp-2.
26637797	0.87	Exp 1) was decreased by 35% by rAAV-GFP-miRC9 (n=4, one-way ANOVA, Bonferroni's multiple comparison, p<0.05), and 24% in the pooled embryo cultures in Exp 2 (not statistically significant; n=3, one-way ANOVA, Bonferroni's multiple comparison).
31990271	0.87	Exp1 and Exp2 for proficient mice and this decrease is larger for proficient compared to naive mice (compare naive vs. proficient in Figure 7Bi and ii).